A protein binding to a minor-group human rhinovirus (HRV2) was purified from HeLa cell culture supernatant. The amino acid sequences of tryptic peptides showed identity with the human low density lipoprotein (LDL) receptor (LDLR). LDL and HRV2 mutually competed for binding sites on human fibroblasts. Cells down-regulated for LDLR expression yielded much less HRV2 upon infection than cells with up-regulated LDLR. Virus also bound to the large subunit of the a2-macroglobulin receptor/LDLRrelated protein (a2MR/LRP). LDLR-deficient fibroblasts yielded considerably less virus in the presence of receptorassociated protein (RAP), providing evidence that a2MR/LRP also acts as a minor group HRV receptor.
a2MR/LRP also acts as a minor group HRV receptor.
Common colds most frequently arise through infection with human rhinoviruses (HRVs) . The 102 antigenically distinct serotypes are divided into two groups based on receptor specificity (1, 2) . The major group binds to the intercellular adhesion molecule 1 (ICAM-1) (3) (4) (5) , and the minor group has been shown to attach to a membrane protein with a relative molecular mass of about 120 kDa (6, 7) . ICAM-1 and the poliovirus receptor (8) are members of the immunoglobulin superfamily. As the three-dimensional structures of representative HRVs from the two different receptor groups (9, 10) and of poliovirus (11) show considerable similarity, it might have been expected that the minor group receptor would also belong to this family. However, in this communication we present evidence that minor-group HRVs gain access to the cell via members of the low density lipoprotein (LDL) receptor (LDLR) family (12, 13) .
MATERIALS AND METHODS
Purification of HRV2-Binding Protein. Two hundred liters of HeLa cell culture supernatant were concentrated ten times by ultrafiltration, dialyzed against 250 liters of H20 containing 0.02% NaN3, and adjusted to contain 20 mM N-methylpiperazine hydrochloride (pH 4.5). Precipitated material was removed, and the filtered supernatant was applied to a 0.5-liter Macroprep 50 Q column (Bio-Rad). Bound material was eluted with the same buffer containing 0.5 M NaCl. After adjustment to pH 7.2 with 1 M Tris HCl (pH 8), the material was loaded onto a 100-ml Lens culinaris lectin column (Pharmacia), and bound protein was eluted with phosphatebuffered saline (PBS) containing 0.5 M a-D-methyl glucopyranoside and precipitated with (NH4)2SO4 at 50o saturation. The precipitate was dissolved in 200 ml of PBS, the solution was passed over a 40-ml Jacalin agarose column (Vector Laboratories), and bound protein was eluted with 120 ml of 0.1 M a-D-methyl galactopyranoside in PBS and precipitated with (NH4)2SO4 as above. The precipitate was dissolved in 20 mM N-methylpiperazine hydrochloride (pH 4.5) and desalted on a PD-10 column (Pharmacia). Protein was applied onto a Mono Q HR 5/5 column (Pharmacia) and eluted with a gradient of 0-0.5 M NaCl in the same buffer. The binding activity was monitored throughout the purification procedure on ligand blots (7) . Active fractions were concentrated to 1.5 ml with a Centricon-30 microconcentrator (Amicon), and the proteins were resolved on a SDS/7.5% polyacrylamide gel under nonreducing conditions. The band corresponding to the binding activity was localized with 0.3 M CuCl2, and the protein was electrophoretically eluted in 50 mM N-ethylmorpholine acetate (pH 8.5) containing 0.1% SDS. To remove any contaminants having the same mobility under nonreducing conditions, the protein was then boiled in sample buffer containing 2-mercaptoethanol, run again on a 7.5% polyacrylamide gel, and eluted as described before, omitting SDS in the elution buffer.
Preparation of Tryptic Peptides, Separation, and Sequence Analysis. Twenty micrograms of HRV2-binding protein obtained from the preparative gel electrophoresis was lyophilized and dissolved in 30 ,ul of 6 M guanidine hydrochloride/ 0.4 M NH4HCO3, pH 7.6; dithiothreitol was added to 4.5 mM. Incubation was at 56°C for 15 min; after cooling, iodoacetamide was added to 8 mM, and the sample was incubated for 15 min at room temperature. Digestion with trypsin (Promega, 800 ng) was for 18 hr at 37°C in 100 mM NH4HCO3 (pH 7.6; final volume 200 .ul). The peptides were separated on a Waters ,Bondapak C18 column with a linear gradient of 0.06% CF3COOH in water to 0.052% CF3COOH/ 80%6 CH3CN/20% H20. Some of the peptides were rechromatographed on a Merck Supersphere C18 column under identical conditions. Selected peptides were subjected to Edman N-terminal sequencing on an Applied Biosystems model 477A gas-phase sequenator.
Construction of pSVL-LDLr+ and pSVL-LDLr-. The expression plasmids pSVL-LDLr+ and pSVL-LDLr-were constructed by ligating the 2.6-kb HindIII fragment (containing the entire coding sequence of the LDLR) from pTZ-1, a derivative of pLDLR-2 (12), with Xba I-digested pSVL (Pharmacia). Both fragments were partially filled in with Klenow fragment before ligation. The orientation ofthe insert was determined by restriction analysis. Transfection was done with the Lipofectin transfection system (GIBCO).
RESULTS AND DISCUSSION
We have previously shown that a protein with binding activity for minor receptor group HRVs was released from HeLa cells upon incubation with buffer at 37°C (14) . This Abbreviations: HRV, human rhinoviruses; LDL, low density lipoprotein; LDLR, LDL receptor; a2MR/LRP, a2-macroglobulin receptor/LDLR-related protein; ICAM-1, intercellular cell adhesion molecule 1; RAP, 39-kDa receptor-associated protein; pfu, plaqueforming unit(s); FH, familial hypercholesterolemia.
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protein was also shed into the medium upon growing the cells under normal tissue culture conditions (not shown). It was purified to homogeneity from HeLa cell culture supernatants by column chromatography and preparative SDS/polyacrylamide gel electrophoresis. The material eluted from the gel migrated as a single band of 160 kDa under reducing conditions and of 120 kDa under nonreducing conditions (Fig. la) . The molecular mass of the soluble binding protein has previously been determined as 84 kDa (14); a protein with this molecular mass recognized by HRV2 on virus overlay blots was also evident as a minor component in the material from the cell culture supernatant. Therefore, we believe the 84-kDa band to be a degradation product ofthe 120-kDa binding protein. In accordance with previous results (7), the nonreduced protein was specifically recognized by HRV2 on ligand blots (Fig. lb) , since it was competitively blocked by the minor-group virus HRV49 but not by the major-group virus HRV89 (see ref. 6 ). The material run under reducing conditions did not attach any virus. Moreover, when a similar ligand blot was incubated with the major-group virus HRV14, no binding was seen under any conditions (7) . The protein eluted from the preparative gel was digested with trypsin, the digest was resolved by reversed-phase HPLC, and selected peptides were subjected to N-terminal protein sequencing. (7); 2, incubated with IgG-C7 and visualized with the ECL (enhanced chemiluminescence) detection system (Amersham). Molecular mass markers in kDa are shown at right. (Fig. 3) . Virus progeny obtained from FH cells was slightly lower with both serotypes in the presence ofthe sterols, probably due to the reduced metabolic activity under these conditions. Surprisingly, however, FH cells that do not express LDLRs at all yielded significantly more HRV2 than did normal fibroblasts with suppressed LDLR expression. This result and the ability of the mutant cells to internalize a small amount of virus ( Fig. 2A) ooaddition to the LDLR in extracts from normal fibroblasts; as expected, the band corresponding to the LDLR was absent in FH cells (Fig. 4) .
Binding ofa variety of ligands to a2MR/LRP is inhibited by RAP (22, 23) . When FH cells were infected in the presence of various concentrations of recombinant RAP, the yield of HRV2 was decreased to about 10%1 at the highest concentration tested (Fig. 5) entry of HRV2 at least in this particular cell line. RAP, which specifically blocks a2MR/LRP, did not reduce the virus yield in normal fibroblasts (not shown). This is consistent with the recent finding of Choi and Cooper (24) , who have shown that on cells expressing the LDLR and a2MR/LRP, the contribution of the latter is difficult to demonstrate for ligands shared by both proteins.
It is an open question why FH cells, which internalize less virus than do normal fibroblasts with down-regulated LDLR expression ( Fig. 2A) lanes 2 and 4) . Note that the nonreduced LDLR (and its presumed degradation product; see also ref. 14) migrate somewhat differently in linear 7.5% gels (compare with Fig. 1) . Molecular masses are shown in kDa. (21, 22) . Cells were grown in 24-well plates and incubated with RAP at 40C for 2 hr at the concentrations indicated. HRV2 was added at a multiplicity of infection of p100, and incubation was continued for an additional 2 hr. The plates were heated to room temperature for 10 min, washed three times with PBS, and incubated for 16 hr at 340C. Infectious virus was determined by plaque assays as described in Fig.  3 . Results are expressed as means ± SD for two duplicate independent determinations.
particles (Fig. 3) . At the present time we hypothesize that the internalization and/or uncoating efficiency of the two receptors could be quite different. It is possible that the affinity of the virus for LDLR is higher than for a2MR/LRP, and therefore most of the virus is internalized by LDLR in those cells that express both macromolecules. However, if this were the case, we have to assume that the uncoating via LDLR would be a rather inefficient process leading to a large percentage of abortively infecting virions. In FH cells, where the LDLR is absent, all virions have to enter via a2MR/LRP, and a much higher percentage of the internalized virus gives rise to productive infection. Apparently, the low amount of residual LDLR present on down-regulated normal fibroblasts might still be able to overcome any effect of a2MR/LRP (24) . Also, since the cells employed in this study are not isogenic, their a2MR/LRP might behave differently. To shed light onto these processes we are currently investigating the kinetic parameters of virus attachment and internalization via the two different receptors. Both receptors are ubiquitous in terms of their presence in almost all tissues of a large variety of species (25) . Therefore, the question of what determines the host specificity as well as the tissue specificity of minor group HRVs remains to be answered.
While this paper was being reviewed, a report on a small protein also related to the LDLR that functions as a receptor for subgroup A Rous sarcoma virus was published (26) . Therefore, similar to the immunoglobulin superfamily, LDLR and LDLR-related proteins now seem to emerge as a new virus receptor family.
The elucidation of the mechanisms by which two completely different classes of receptors-i.e., ICAM-1 for major-group HRVs and LDLR and/or a2MR/LRP for minorgroup HRVs-are utilized by structurally and functionally very similar viruses is of fundamental importance.
